Trial Profile
Donepezil in Early Dementia Associated with Parkinson's Disease: Multicentre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated with Parkinson's Disease
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 25 Jul 2022
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Dementia; Parkinson's disease
- Focus Therapeutic Use
- Acronyms MUSTARDD-PD
- 05 Apr 2017 Status changed to discontinued.
- 01 Aug 2014 Status changed from suspended to completed as reported by United Kingdom Clinical Research Network record.
- 19 Jun 2014 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.